Number of metastatic organs negatively affects the treatment sequence in patients with EGFR‐TKI failure

BACKGROUND: Several studies have previously demonstrated the survival benefit of both EGFR‐TKI treatment and chemotherapy in patients with non‐small cell lung cancer (NSCLC) harboring EGFR mutations. The aim of the present study was to clarify the factors influencing the treatment sequence after fai...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizuno, Takaaki, Horinouchi, Hidehito, Watanabe, Sho, Sato, Jun, Morita, Ryo, Murakami, Shuji, Goto, Yasushi, Kanda, Shintaro, Fujiwara, Yutaka, Yamamoto, Noboru, Ohe, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113048/
https://www.ncbi.nlm.nih.gov/pubmed/32077630
http://dx.doi.org/10.1111/1759-7714.13360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113048/
https://www.ncbi.nlm.nih.gov/pubmed/32077630
http://dx.doi.org/10.1111/1759-7714.13360

Ejemplares similares